Biosimilar Monoclonal Antibodies Market Opportunities, Challenges, Strategies & Forecasts
Biosimilar Monoclonal Antibodies Market Opportunities, Challenges, Strategies & Forecasts
The Global Biosimilar Monoclonal Antibodies Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Celltrion,, Pfizer (Hospira),, 3SBIO,, Novartis (Sandoz),, Dr Reddy’s,, Celgen Biopharma,, Cadila Healthcare,, Hisun Pharma,, Torrent Pharmaceuticals,,
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Biosimilar Monoclonal Antibodies market was valued at $XX million in 2020, and MAResearch analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to all countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020 and 2021.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for Biosimilar Monoclonal Antibodies from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Monoclonal Antibodies market.
Leading players of Biosimilar Monoclonal Antibodies including:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
Market split by Type, can be divided into:
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Market split by Application, can be divided into:
Oncology
Autoimmune Disease
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Chapter 1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Biosimilar Monoclonal Antibodies Definition
1.2 Global Biosimilar Monoclonal Antibodies Market Size Status and Outlook (2015-2030)
1.3 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Region (2015-2030)
1.4 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Type (2015-2030)
1.5 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Application (2015-2030)
1.6 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Sales Channel (2015-2030)
1.7 Biosimilar Monoclonal Antibodies Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biosimilar Monoclonal Antibodies Market Segment Analysis by Player
2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Player (2018-2020)
2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2018-2020)
2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Monoclonal Antibodies Market Segment Analysis by Type
3.1 Global Biosimilar Monoclonal Antibodies Market by Type
3.1.1 Infliximab
3.1.2 Rituximab
3.1.3 Trastuzumab
3.1.4 Adalimumab
3.1.5 Other
3.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2015-2020)
3.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
3.4 Global Biosimilar Monoclonal Antibodies Average Price by Type (2015-2020)
3.5 Leading Players of Biosimilar Monoclonal Antibodies by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Monoclonal Antibodies Market Segment Analysis by Application
4.1 Global Biosimilar Monoclonal Antibodies Market by Application
4.1.1 Oncology
4.1.2 Autoimmune Disease
4.1.3 Other
4.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Monoclonal Antibodies Market Segment Analysis by Sales Channel
5.1 Global Biosimilar Monoclonal Antibodies Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Monoclonal Antibodies Market Segment Analysis by Region
6.1 Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2015-2030)
6.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2015-2020)
6.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Monoclonal Antibodies Market Share by Type
6.4.3 North America Biosimilar Monoclonal Antibodies Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Monoclonal Antibodies Market Share by Type
6.5.3 Europe Biosimilar Monoclonal Antibodies Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type
6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Monoclonal Antibodies Market Share by Type
6.7.3 South America Biosimilar Monoclonal Antibodies Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type
6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies Players
7.1 Celltrion
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Celltrion
7.2 Pfizer (Hospira)
7.3 3SBIO
7.4 Novartis (Sandoz)
7.5 Dr Reddy’s
7.6 Celgen Biopharma
7.7 Cadila Healthcare
7.8 Hisun Pharma
7.9 Torrent Pharmaceuticals
Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies
8.1 Industrial Chain of Biosimilar Monoclonal Antibodies
8.2 Upstream of Biosimilar Monoclonal Antibodies
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Biosimilar Monoclonal Antibodies
8.3.1 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies
8.3.2 Leading Consumers of Biosimilar Monoclonal Antibodies
Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (2021-2030)
9.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales and Revenue) Forecast (2021-2030)
9.2 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2021-2030)
9.3 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2021-2030)
9.4 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2021-2030)
9.5 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
Research Methodology:
Biosimilar Monoclonal Antibodies Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|